Navigation Links
Vanda Pharmaceuticals Reports Second Quarter 2011 Results
Date:8/4/2011

) for the commercialization of Fanapt® in Argentina.
  • The first tasimelteon Non-24-Hour Sleep-Wake Disorder (N24HSWD or Non-24) Phase III pivotal study continues its enrollment.  New international clinical sites were added during the quarter.  

  • SECOND QUARTER 2011 REPORTED RESULTSTotal revenues for the second quarter of 2011 were $7.4 million, compared to $8.3 million for the same period in 2010.  Second quarter 2011 revenues included $0.8 million related to Fanapt® royalties received from Novartis as compared to $0.1 million for the second quarter of 2010.  Second quarter 2011 sales of Fanapt® as reported by Novartis included a $2.7 million cumulative adjustment to gross to net sales reserves that resulted in approximately $270 thousand less in royalties to Vanda in the period. Second quarter 2010 revenues also included one-time product sales to Novartis of $1.5 million.  Total operating expenses for the second quarter of 2011 were $8.9 million, compared to $7.1 million for the second quarter of 2010.  The primary driver of the higher expenses in the second quarter of 2011 was the ongoing support of the tasimelteon N24HSWD clinical studies.

    A net loss of $1.3 million was recorded for the second quarter of 2011, compared to net income of $1.3 million for the second quarter of 2010.  Diluted net loss per share for the second quarter of 2011 was $0.05, compared to diluted net income of $0.04 per share for the second quarter of 2010. Year to date June 30, 2011 Key Financial Figures(1) Six Months Ending June 30June 30(in thousands, except per share amounts)

    20112010  Change ($)Change (%)Total revenues

    $
    4,931$
    20,711$
    (5,780)-28%Research & development  expenses

    10,2664,4445,822131%General & administrative expenses

    5,4305,331992%Non-cash stock-based compensation(2)

    2,9292,7601696%Income (loss) before t
    '/>"/>

    SOURCE Vanda Pharmaceuticals Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Vanda Pharmaceuticals Submits Iloperidone New Drug Application
    2. Vanda Pharmaceuticals Reports Third Quarter 2007 Results
    3. Vanda Pharmaceuticals Receives FDA Acceptance of Iloperidone New Drug Application
    4. Vanda Presents Phase III Iloperidone Efficacy Data
    5. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
    6. Vanda Pharmaceuticals Provides Update on Iloperidone
    7. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
    8. FDA Approves Vanda Pharmaceuticals Fanapt(TM) for the Treatment of Schizophrenia
    9. Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
    10. Vanda Pharmaceuticals Announces Expiration of Hart-Scott -Rodino Waiting Period for Exclusive License of Fanapt(TM)
    11. Vanda Pharmaceuticals Announces U.S. Patent Allowance for a Long-Acting Injectable Formulation of Fanapt(TM) (iloperidone) in the U.S.
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)... -- ResMed (NYSE: RMD ) today announced its ... device manufacturer BMC Medical Co., Ltd. The ... below infringe ResMed,s patents, and entered an order prohibiting BMC ... the United States : , iVolve nasal ... nasal pillows mask , iVolve full face mask ...
    (Date:12/24/2014)...   Assurex Health, a personalized medicine company ... for behavioral health and chronic pain conditions, today ... equity financing from new and existing investors, according ... Chief Executive Officer. The financing will ... Health,s GeneSight ®  products.  GeneSight,s patented ...
    (Date:12/24/2014)... 2014 Tianyin Pharmaceutical Co., Inc. (NYSE ... patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded ... that the Company achieved the Public Notice (Gong ... certificate of TPI,s Qionglai Facility (QLF) from the ... notice period is a significant procedure of GMP ...
    Breaking Medicine Technology:ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3
    ... BLUE BELL, Pa., Feb. 24, 2011 Inovio Pharmaceuticals, Inc. ... development of therapeutic and preventive vaccines against cancers and infectious ... CEO will present a company overview at the Cowen & ... at the Boston Marriott Copley Place in Boston, MA. ...
    ... 2011 Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ ) ... the Citi 2011 Global Health Care Conference in New York ...  Bruce Cozadd, the company,s chairman and chief executive officer, will ... the presentation may be accessed from the Investors section of ...
    Cached Medicine Technology:Inovio Pharmaceuticals to Present at Cowen & Co. Health Care Conference 2Inovio Pharmaceuticals to Present at Cowen & Co. Health Care Conference 3
    (Date:12/25/2014)... (PRWEB) December 26, 2014 ... BambooFlooringChina.com combines beauty, strength and durability. Today, the ... promotion, which is valid until Jan. 30, 2015. ... grain of traditional hardwood. BambooFlooringChina.com is a well-known ... help consumers worldwide to find a reliable bamboo ...
    (Date:12/25/2014)... three months the trends for evening dresses shift ... one of the hottest styles in the next few months.” ... releases 26 A-line sweetheart evening dresses, and announces the availability ... are trying our best to help a lady to show ... affordable prices, we provide discounted delivery costs to our customers ...
    (Date:12/25/2014)... Recently, BellasDress has launched its Christmas Sale, ... has chosen their best-selling lace wedding dresses, vintage bridesmaid ... season. , Now, BellasDress.com features popular women’s dresses, ... discount prices. The business hopes everyone can have a ... , “All our elegant products are made with exquisite ...
    (Date:12/25/2014)... Recently, LunaDress.co.uk has updated its blog to provide professional shopping ... of the models at LunaDress.co.uk come with big discounts, up to ... veil can turn out to be a most exciting memory and ... always bring surprise to a wedding. On the updated fashion blog, ... veils for a big day . , Going out with friends ...
    (Date:12/25/2014)... 2014 (HealthDay News) -- Among early stage breast cancer ... half of one percent will eventually develop leukemia as ... The finding comes from a review of more ... 2007, and it suggests that the risk for developing ... had previously thought. "The frequency of bone marrow ...
    Breaking Medicine News(10 mins):Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3
    ... Reporter , MONDAY, March 28 (HealthDay News) -- Radiation ... airline passengers is not a significant health threat, University ... since the U.S. Transportation Safety Administration (TSA) installed full-body ... 486 scanners in 78 U.S. airports, and it plans ...
    ... Amanda Gardner HealthDay Reporter , MONDAY, March 28 ... traditional exposure therapy may help anxious patients overcome their fear ... exposing people to the thing they fear -- be it ... But while promising, this experimental treatment is not ...
    ... surgery should be considered earlier in the treatment of ... can result from diabetes, according to an International Diabetes ... the 2nd World Congress on Interventional Therapies for Type ... written by 20 leading experts in diabetes and bariatric ...
    ... water they pass through and also affect the distribution carbon-dioxide-absorbing ... researchers from UC San Diego and the University of San ... the growth of phytoplankton in the Atlantic sector of the ... Alley" east of the Antarctic Peninsula. Enhanced phytoplankton growth ...
    ... News) -- Seeing other people scratching can cause your ... The team at Wake Forest Baptist Medical Center investigated ... "It is conceivable that the neuronal networks or mechanisms ... involved in contagious yawning, a phenomenon that is still ...
    ... the differences in heart disease among women and men ... as gender and ethnicity matter when it comes to ... Transgender People: Building a Foundation for Understanding, a new ... ensure that clinical researchers identify and address the needs ...
    Cached Medicine News:Health News:Airport Scanners Appear Safe, Study Finds 2Health News:Airport Scanners Appear Safe, Study Finds 3Health News:Airport Scanners Appear Safe, Study Finds 4Health News:Stress Hormone Might Help Overcome Fear of Heights 2Health News:International Diabetes Federation supports surgery to treat diabetes 2Health News:International Diabetes Federation supports surgery to treat diabetes 3Health News:Icebergs in the Antarctic play important role in carbon cycle 2Health News:Seeing Others Scratch Can Trigger Your Own Itch 2
    ... I system is a unique ... combines dual width capability with ... roll" design. Specifically developed to ... patients, the easy-to-use Tri-Flex I ...
    ... offer a wide selection of solutions for ... use. The sterile water for inhalation and ... plastic pour bottles in 500 and 1000mL ... nebulizer kits or can be used alone ...
    ... FIO 2 500ML 0.9% Sodium Chloride ... provide unmatched performance and ease of use. You ... from 28% to 100% FIO 2 . We ... for inhalation, USP; 0.45% sodium chloride inhalation, USP; ...
    ... NEBULIZER EMPTY W/AIR ENT 35%-100% FIO2, ... adjustable from 35% to 100%. It has ... immersion-type heater., ,Empty Nebulizers 5007P and ... to 98%. , ,Convenient slip-on heaters ...
    Medicine Products: